ESTIMATION OF LIVER IRON CONCENTRATION BY SERUM FERRITIN MEASUREMENT IN NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS: ANALYSIS FROM THE 1-YEAR THALASSA STUDY

被引：0
|
作者：
Taher, A. [1 ]
Porter, J. [2 ]
Viprakasit, V. [3 ]
Kattamis, A. [4 ]
Chuncharunee, S. [5 ]
Sutcharitchan, P. [6 ,7 ]
Siritanaratkul, N. [3 ]
Galanello, R. [8 ]
Karakas, Z. [9 ]
Lawniczek, T. [10 ]
Habr, D. [11 ]
Ros, J. [10 ]
Zhang, Y. [11 ]
Cappellini, D. [12 ]
机构：
[1] Amer Univ Beirut, Beirut, Lebanon
[2] UCL, London, England
[3] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand
[4] Univ Athens, Dept Pediat 1, Athens, Greece
[5] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
[6] Chulalongkorn Univ, Bangkok, Thailand
[7] King Chulalongkorn Mem Hosp, Bangkok, Thailand
[8] Univ Cagliari, Osped Reg Microcitemie, Cagliari, Italy
[9] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey
[10] Novartis Pharma AG, Basel, Switzerland
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Univ Milan, Ca Granda Fdn IRCCS, Milan, Italy
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0927
引用
收藏
页码：383 / 383
页数：1
相关论文
共 50 条
  • [21] Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients
    Pakbaz, Zahra
    Fischer, Roland
    Fung, Ellen
    Nielsen, Peter
    Harmatz, Paul
    Vichinsky, Elliott
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 329 - 332
  • [22] Iron Overload in a Patient with Non-Transfusion-Dependent Hemoglobin H Disease and Borderline Serum Ferritin: Can We Rely on Serum Ferritin for Monitoring in This Group of Patients?
    Ali, Mohammad
    Yassin, Mohamed A.
    Aldeeb, Maya
    CASE REPORTS IN ONCOLOGY, 2020, 13 (02): : 668 - 673
  • [23] FACTORS ASSOCIATED WITH IRON ACCUMULATION IN NON-TRANSFUSION-DEPENDENT THALASSAEMIA SYNDROMES: BASELINE DATA FROM MULTICENTER INTERNATIONAL DEFERASIROX STUDY (THALASSA)
    Taher, A.
    Viprakasit, V.
    Porter, J.
    Kattamis, A.
    Lawniczek, T.
    Pereno, R.
    Schoenborn-Kellenberger, O.
    Cappellini, M. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 707 - 707
  • [24] Organ-Specific Iron Overload in Non-Transfusion-Dependent Thalassemia Patients: Insights from Quantitative MRI Evaluation
    Ning, Xiaojing
    Tan, Siyu
    Peng, Fei
    Luo, Chaotian
    Tang, Cheng
    Xiao, Fangyan
    Peng, Peng
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 181
  • [25] Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia
    Taher, Ali T.
    Porter, John B.
    Viprakasit, Vip
    Kattamis, Antonis
    Chuncharunee, Suporn
    Sutcharitchan, Pranee
    Siritanaratkul, Noppadol
    Origa, Raffaella
    Karakas, Zeynep
    Habr, Dany
    Zhu, Zewen
    Cappellini, Maria Domenica
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (02) : 284 - 290
  • [26] PlGF and sFlt-1 levels in patients with non-transfusion-dependent thalassemia: Correlations with markers of iron burden and endothelial dysfunction
    Kelaidi, Charikleia
    Kattamis, Antonis
    Apostolakou, Filia
    Poziopoulos, Christos
    Lazaropoulou, Christina
    Delaporta, Polyxeni
    Kanavaki, Ino
    Papassotiriou, Ioannis
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 100 (06) : 630 - 635
  • [27] Limitations of serum ferritin to predict liver iron concentration responses to deferasirox therapy in patients with transfusion-dependent thalassaemia
    Porter, John B.
    Elalfy, Mohsen
    Taher, Ali
    Aydinok, Yesim
    Lee, Szu-Hee
    Sutcharitchan, Pranee
    El-Ali, Ali
    Han, Jackie
    El-Beshlawy, Amal
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (03) : 280 - 288
  • [28] An open-label, multicenter, efficacy, and safety study of deferasirox in iron-overloaded patients with non-transfusion-dependent thalassemia (THETIS): 5-year results
    Lai, Yong-Rong
    Cappellini, Maria Domenica
    Aydinok, Yesim
    Porter, John
    Karakas, Zeynep
    Viprakasit, Vip
    Siritanaratkul, Noppadol
    Kattamis, Antonis
    Liu, Rongrong
    Izquierdo, Miguel
    Lasher, Janet
    Govindaraju, Sameera
    Taher, Ali
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (08) : E281 - E284
  • [29] THE SAFETY PROFILE OF DEFERASIROX REMAINS CONSISTENT AS NON-TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS APPROACH THE TARGET LIVER IRON CONCENTRATION OF <3 MG FE/G DW FOR INTERRUPTING CHELATION
    Taher, A.
    Porter, J.
    Viprakasit, V.
    Kattamis, A.
    Chuncharunee, S.
    Sutcharitchan, P.
    Siritanaratkul, N.
    Galanello, R.
    Karakas, Z.
    Habr, D.
    Zhu, Z.
    Cappellini, M.
    HAEMATOLOGICA, 2013, 98 : 165 - 166
  • [30] Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia
    Zekavat, Omid Reza
    Jahromi, Mahshid Zareian
    Haghpanah, Sezaneh
    Jahromi, Zahra Kargar
    Cohan, Nader
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (01) : E26 - E28
12345